The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,148,645 in first-year total cost, median $206,987.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]13
- Special Emphasis Panel[ZAR1 KM (M2)]1
Most frequent institutions
- OREGON HEALTH & SCIENCE UNIVERSITY2
- UNIVERSITY OF SOUTHERN CALIFORNIA2
- BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)1
- CINCINNATI CHILDRENS HOSP MED CTR1
- CLEVELAND CLINIC LERNER COM-CWRU1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Parent-directed remote identification and severity assessments enabling decentralized trials in atopic dermatitis1R01AR082107-01A1 | SIMPSON, ERIC L | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $402,616 | AMSC |
| 2024 | Autosomal Dominant Osteopetrosis: A Natural History Study1R01AR084202-01 | ECONS, MICHAEL J | INDIANA UNIVERSITY INDIANAPOLIS, IN | $255,022 | ZAR1 |
| 2024 | Patient-Specific Factors of Recovery in Rotator Cuff Tendinopathy1R01AR083626-01A1 | MICHENER, LORI ANN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $238,916 | AMSC |
| 2024 | Natural history and validation of surrogate biomarkers and patient-reported outcomes for SJIA-LD1R01AR084717-01 | KIMURA, YUKIKOSCHULERT, GRANT SANFORD | CINCINNATI CHILDRENS HOSP MED CTR, OH | $206,016 | AMSC |
| 2024 | An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva1R01AR083628-01 | HSIAO, EDWARD C | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $177,650 | AMSC |
| 2024 | Hip structure and function in young female athletes1R01AR083148-01A1 | LEWIS, CARA L | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $165,000 | AMSC |
| 2024 | Evaluating Over Constraint of the Patella following MPFL Reconstruction as a Contributing Factor to Progressive Cartilage Degradation1R01AR084758-01 | ELIAS, JOHN JLI, XIAOJUAN | CLEVELAND CLINIC LERNER COM-CWRU, OH | $161,000 | AMSC |
| 2023 | Diagnostic and treatment landscape of pyoderma gangrenosum1R01AR083110-01 | ORTEGA LOAYZA, ALEX | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $257,008 | AMSC |
| 2023 | Influence of the Microbiome on the Natural History of Alopecia Areata1R01AR079744-01A1 | CHRISTIANO, ANGELA M | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $253,330 | AMSC |
| 2023 | Assessment of Treatment Satisfaction in Psoriasis1R01AR081226-01A1 | ARMSTRONG, APRIL W | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $200,292 | AMSC |
| 2023 | Novel digital tools for home-based monitoring of skin disease1R01AR082109-01 | LINOS, ELENI | STANFORD UNIVERSITY, CA | $170,500 | AMSC |
| 2022 | Developing an Objective and Quantifiable Measure of Itch Using Artificial Intelligence and Radio Signals1R01AR080392-01 | KATABI, DINA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $276,902 | AMSC |
| 2022 | Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease1R01AR080356-01 | ASCHERMAN, DANA PDOMSIC, ROBYN THERESE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $207,958 | AMSC |
| 2022 | MRI Bone Texture: A Novel Biomarker for Assessment of Bone Quality and Prediction of Complications in Patients Having Spine Fusion Surgery1R01AR081574-01 | STEIN, EMILY MARGARET | HOSPITAL FOR SPECIAL SURGERY, NY | $176,435 | AMSC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.